{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:44:51Z","timestamp":1790390691056,"version":"4.1.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T00:00:00Z","timestamp":1540512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1093\/toxsci\/kfy264","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T22:41:10Z","timestamp":1540507270000},"page":"573-580","source":"Crossref","is-referenced-by-count":19,"title":["Resolving the Reversed Rate Effect of Calcium Channel Blockers on Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes and the Impact on In Vitro Cardiac Safety Evaluation"],"prefix":"10.1093","volume":"167","author":[{"given":"Haoyu","family":"Zeng","sequence":"first","affiliation":[{"name":"Safety and Exploratory Pharmacology, Merck & Co., Inc., West Point, Pennsylvania 19486-0004"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixin","family":"Wang","sequence":"additional","affiliation":[{"name":"Safety and Exploratory Pharmacology, Merck & Co., Inc., West Point, Pennsylvania 19486-0004"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Clouse","sequence":"additional","affiliation":[{"name":"Safety and Exploratory Pharmacology, Merck & Co., Inc., West Point, Pennsylvania 19486-0004"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Lagrutta","sequence":"additional","affiliation":[{"name":"Safety and Exploratory Pharmacology, Merck & Co., Inc., West Point, Pennsylvania 19486-0004"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Sannajust","sequence":"additional","affiliation":[{"name":"Safety and Exploratory Pharmacology, Merck & Co., Inc., West Point, Pennsylvania 19486-0004"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,10,26]]},"reference":[{"key":"key\n\t\t\t\t2019020115294386600_kfy264-B1","first-page":"707","article-title":"Effects of dihydropyridine calcium-antagonists on intracellular action potentials of rabbit sinus node, atrium and atrioventricular node. Comparison of felodipine with nifedipine","volume":"44","author":"Beyer","year":"1994","journal-title":"Arzneimittelforschung"},{"key":"key\n\t\t\t\t2019020115294386600_kfy264-B2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.scr.2009.11.004","article-title":"Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes","volume":"4","author":"Braam","year":"2010","journal-title":"Stem Cell Res"},{"key":"key\n\t\t\t\t2019020115294386600_kfy264-B3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.vascn.2012.08.167","article-title":"High throughput measurement of Ca(2)(+) dynamics for drug risk assessment in human stem cell-derived cardiomyocytes by kinetic image cytometry","volume":"66","author":"Cerignoli","year":"2012","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"key\n\t\t\t\t2019020115294386600_kfy264-B4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.vascn.2016.06.002","article-title":"The comprehensive in vitro proarrhythmia assay (CiPA) initiative - Update on progress","volume":"81","author":"Colatsky","year":"2016","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"key\n\t\t\t\t2019020115294386600_kfy264-B5","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/00005344-199311000-00002","article-title":"Comparison of antiarrhythmic and electrophysiologic effects of diltiazem and its analogue siratiazem","volume":"22","author":"Guc","year":"1993","journal-title":"J. Cardiovasc. Pharmacol"},{"key":"key\n\t\t\t\t2019020115294386600_kfy264-B6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/toxsci\/kfr158","article-title":"Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes","volume":"123","author":"Guo","year":"2011","journal-title":"Toxicol. Sci"},{"key":"key\n\t\t\t\t2019020115294386600_kfy264-B7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/toxsci\/kft205","article-title":"Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model","volume":"136","author":"Guo","year":"2013","journal-title":"Toxicol. Sci"},{"key":"key\n\t\t\t\t2019020115294386600_kfy264-B8","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1161\/01.CIR.59.4.797","article-title":"Reversal of the cardiovascular effects of verapamil by calcium and sodium: differences between electrophysiologic and hemodynamic responses","volume":"59","author":"Hariman","year":"1979","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019020115294386600_kfy264-B9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.vascn.2017.02.001","article-title":"CSAHi study: detection of drug-induced ion channel\/receptor responses, QT prolongation, and arrhythmia using multi-electrode arrays in combination with human induced pluripotent stem cell-derived cardiomyocytes","volume":"85","author":"Kitaguchi","year":"2017","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"key\n\t\t\t\t2019020115294386600_kfy264-B10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.vascn.2015.12.002","article-title":"CSAHi study: Evaluation of multi-electrode array in combination with human iPS cell-derived cardiomyocytes to predict drug-induced QT prolongation and arrhythmia\u2013Effects of 7 reference compounds at 10 facilities","volume":"78","author":"Kitaguchi","year":"2016","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"key\n\t\t\t\t2019020115294386600_kfy264-B11","doi-asserted-by":"crossref","first-page":"44820","DOI":"10.1038\/srep44820","article-title":"Cardiac drug-drug interaction between HCV-NS5B pronucleotide inhibitors and amiodarone is determined by their specific diastereochemistry","volume":"7","author":"Lagrutta","year":"2017","journal-title":"Sci. Rep"},{"key":"key\n\t\t\t\t2019020115294386600_kfy264-B12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.taap.2016.08.006","article-title":"Interaction between amiodarone and hepatitis-C virus nucleotide inhibitors in human induced pluripotent stem cell-derived cardiomyocytes and HEK-293 Cav1.2 over-expressing cells","volume":"308","author":"Lagrutta","year":"2016","journal-title":"Toxicol. Appl. Pharmacol"},{"key":"key\n\t\t\t\t2019020115294386600_kfy264-B13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.vascn.2017.05.001","article-title":"Application of optical action potentials in human induced pluripotent stem cells-derived cardiomyocytes to predict drug-induced cardiac arrhythmias","volume":"87","author":"Lu","year":"2017","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"key\n\t\t\t\t2019020115294386600_kfy264-B14","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/toxsci\/kfv201","article-title":"High throughput measurement of Ca++ dynamics in human stem cell-derived cardiomyocytes by kinetic image cytometery: A cardiac risk assessment characterization using a large panel of cardioactive and inactive compounds","volume":"148","author":"Lu","year":"2015","journal-title":"Toxicol. Sci"},{"key":"key\n\t\t\t\t2019020115294386600_kfy264-B15","doi-asserted-by":"crossref","first-page":"H2006","DOI":"10.1152\/ajpheart.00694.2011","article-title":"High purity human-induced pluripotent stem cell-derived cardiomyocytes: Electrophysiological properties of action potentials and ionic currents","volume":"301","author":"Ma","year":"2011","journal-title":"Am. J. Physiol Heart Circ. Physiol."},{"key":"key\n\t\t\t\t2019020115294386600_kfy264-B16","first-page":"59","article-title":"On the mechanism of the anti-hypertensive effect of Ca++-blockers","volume":"51","author":"Marmo","year":"1986","journal-title":"Res. Commun. Chem. Pathol. Pharmacol"},{"key":"key\n\t\t\t\t2019020115294386600_kfy264-B17","first-page":"327","article-title":"Profound sinus bradycardia due to diltiazem, verapamil, and\/or beta-adrenergic blocking drugs","volume":"156","author":"Mills","year":"2004","journal-title":"J. La State Med. Soc"},{"key":"key\n\t\t\t\t2019020115294386600_kfy264-B18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12012-014-9268-9","article-title":"Human stem cell-derived cardiomyocytes in cellular impedance assays: Bringing cardiotoxicity screening to the front line","volume":"15","author":"Peters","year":"2015","journal-title":"Cardiovasc. Toxicol"},{"key":"key\n\t\t\t\t2019020115294386600_kfy264-B19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41586-018-0016-3","article-title":"Advanced maturation of human cardiac tissue grown from pluripotent stem cells","volume":"556","author":"Ronaldson-Bouchard","year":"2018","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019020115294386600_kfy264-B20","doi-asserted-by":"crossref","first-page":"II42","DOI":"10.1161\/01.HYP.11.3_Pt_2.II42","article-title":"Side effects of calcium channel blockers","volume":"11","author":"Russell","year":"1988","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t2019020115294386600_kfy264-B21","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1111\/bph.13577","article-title":"Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: Has the time come?","volume":"174","author":"Sala","year":"2017","journal-title":"Br. J. Pharmacol"},{"key":"key\n\t\t\t\t2019020115294386600_kfy264-B22","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1002\/stem.2403","article-title":"Concise review: Measuring physiological responses of human pluripotent stem cell derived cardiomyocytes to drugs and disease","volume":"34","author":"van Meer","year":"2016","journal-title":"Stem Cells"},{"key":"key\n\t\t\t\t2019020115294386600_kfy264-B23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.vascn.2017.12.004","article-title":"Response of human induced pluripotent stem cell-derived cardiomyocytes to several pharmacological agents when intrinsic syncytial pacing is overcome by acute external stimulation","volume":"91","author":"Zeng","year":"2018","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"key\n\t\t\t\t2019020115294386600_kfy264-B24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.vascn.2016.05.009","article-title":"Use of FDSS\/muCell imaging platform for preclinical cardiac electrophysiology safety screening of compounds in human induced pluripotent stem cell-derived cardiomyocytes","volume":"81","author":"Zeng","year":"2016","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"key\n\t\t\t\t2019020115294386600_kfy264-B25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.vascn.2016.06.004","article-title":"Multi-parametric assessment of cardiomyocyte excitation-contraction coupling using impedance and field potential recording: A tool for cardiac safety assessment","volume":"81","author":"Zhang","year":"2016","journal-title":"J. Pharmacol. Toxicol. Methods"}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/toxsci\/article-pdf\/167\/2\/573\/27694615\/kfy264.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T11:31:49Z","timestamp":1572262309000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/toxsci\/article\/167\/2\/573\/5145095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,26]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,10,26]]},"published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfy264","relation":{},"ISSN":["1096-6080","1096-0929"],"issn-type":[{"value":"1096-6080","type":"print"},{"value":"1096-0929","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2]]},"published":{"date-parts":[[2018,10,26]]}}}